发明授权
- 专利标题： MET-binding agents and uses thereof
- 专利标题（中）： MET结合剂及其用途
-
申请号： US14212177申请日： 2014-03-14
-
公开(公告)号： US09168300B2公开(公告)日： 2015-10-27
- 发明人: Austin L. Gurney , Ming-Hong Xie , Christopher John Bond
- 申请人： OncoMed Pharmaceuticals, Inc.
- 申请人地址： US CA Redwood City
- 专利权人： OncoMed Pharmaceuticals, Inc.
- 当前专利权人： OncoMed Pharmaceuticals, Inc.
- 当前专利权人地址： US CA Redwood City
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K14/71 ; C07K16/28 ; A61K39/00
摘要：
The present invention relates to binding agents that specifically bind human MET, binding agents that specifically bind one or more components of the WNT pathway, bispecific agents that bind both human MET and one or more components of the WNT pathway, and methods of using the agents for treating diseases such as cancer.
公开/授权文献
- US20140286951A1 MET-BINDING AGENTS AND USES THEREOF 公开/授权日：2014-09-25
信息查询
